
Topic
Radiation Oncology
36 Podcasts • 10 Cases on BackTable
Hear how experienced clinicians in Radiation Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Episode # 50 • 10 Mar 2026
Beyond the Beam: Integrating Radiopharmaceuticals into Modern Oncology Practice
Though relatively new, there is a rapidly growing interest in the field of therapeutic radiopharmaceuticals and their potential to play a significant role in cancer treatment. This episode of BackTable Tumor Board covers recent developments in radiopharmaceutical therapies with radiation oncologists Dr. Dustin Boothe and Dr. Ryan Funk, where they discuss efficacy, side effects, and better tolerability of modern radiopharmaceuticals compared to older ones.
This podcast is supported by
More on Radiation Oncology
Loading recent podcasts…
Tumor Board Episode #50
Mar 10, 2026
with Dr. Ryan Funk, Dr. Dustin Boothe
Though relatively new, there is a rapidly growing interest in the field of therapeutic radiopharmaceuticals and their...
280+ listens
Urology Episode #287
Jan 30, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
1,300+ listens
Tumor Board Episode #42
Jan 6, 2026
with Dr. Rebecca Snyder, Dr. Jonathan Mizrahi
For the small subset of pancreatic cancer patients whose cancer is detected early and remains localized, there are now...
160+ listens
VI Episode #599
Dec 19, 2025
with Dr. Scott Oh, Dr. Alan Lee, Dr. Robert Suh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Collaboration between interventional radiology and radiation oncology has enabled high-dose brachytherapy in central...
1,400+ listens
Tumor Board Episode #48
Feb 17, 2026
with Dr. Erika Hamilton, Dr. Lindsay Peterson
In a patient with metastatic HER2-positive breast cancer, what should guide the next decision: trial data, toxicity, or...
180+ listens
Tumor Board Episode #45
Jan 27, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
1,300+ listens
VI Episode #603
Jan 2, 2026
with Dr. Robert Suh, Dr. Alan Lee, Dr. Scott Oh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might simultaneous ablation and biopsy be the new standard for high-probability lung cancer cases where surgery...
1,500+ listens
VI Episode #597
Dec 12, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might the standard RECIST criteria fail to accurately track success after tumor ablation, and what should you look...
1,500+ listens
VI Case
Nov 21, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
VI Case
Nov 21, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Nov 11, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Urology Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
VI Case
Nov 21, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Nov 11, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Nov 11, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
Urology Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.






